Samarendra Mohanty

Company: Nanoscope Therapeutics

Job title: Chief Scientific Officer

Seminars:

Discussing Innovative Approaches in Gene Therapy for AMD by Targeting Inflammation, Establishing Retinal Bio-Factories as Long- Lasting Solutions 1:30 pm

Exploring cutting-edge research in gene therapy targeting inflammatory pathways associated with the complement system dysregulation in AMD Discussing gene delivery vectors and viral vectors engineered to express therapeutic proteins locally in the retina, effectively turning it into a bio-factory Overcoming the challenge of frequent, invasive injections by developing long-lasting gene therapies as a once-and-done treatment…Read more

day: Conference Day Two